New Results
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
Fabienne Lamballe, Fahmida Ahmad, Yaron Vinik, Olivier Castellanet, Fabrice Daian, Anna-Katharina Müller, Ulrike A. Köhler, Anne-Laure Bailly, Emmanuelle Josselin, Rémy Castellano, Christelle Cayrou, Emmanuelle Charafe-Jauffret, Gordon B. Mills, Vincent Géli, Jean-Paul Borg, Sima Lev, View ORCID ProfileFlavio Maina
doi: https://doi.org/10.1101/2020.06.22.164418
Fabienne Lamballe
1Aix Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille (France)
Fahmida Ahmad
1Aix Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille (France)
Yaron Vinik
2Weizmann Institute of Science, Department of Molecular Cell Biology, Rehovot (Israel)
Olivier Castellanet
1Aix Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille (France)
Fabrice Daian
1Aix Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille (France)
Anna-Katharina Müller
2Weizmann Institute of Science, Department of Molecular Cell Biology, Rehovot (Israel)
Ulrike A. Köhler
2Weizmann Institute of Science, Department of Molecular Cell Biology, Rehovot (Israel)
Anne-Laure Bailly
3Aix Marseille Univ, Centre de Recherche en Cancérologie de Marseille (CRCM), Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’, Inserm, CNRS, Institut Paoli-Calmettes, Marseille (France)
Emmanuelle Josselin
4Aix Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, TrGET Platform, Marseille (France)
Rémy Castellano
4Aix Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, TrGET Platform, Marseille (France)
Christelle Cayrou
3Aix Marseille Univ, Centre de Recherche en Cancérologie de Marseille (CRCM), Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’, Inserm, CNRS, Institut Paoli-Calmettes, Marseille (France)
Emmanuelle Charafe-Jauffret
5Aix Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Experimental Histo-Pathology Platform, Marseille (France)
Gordon B. Mills
6Knight Cancer Institute, Portland, OR 97201, USA
Vincent Géli
3Aix Marseille Univ, Centre de Recherche en Cancérologie de Marseille (CRCM), Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’, Inserm, CNRS, Institut Paoli-Calmettes, Marseille (France)
Jean-Paul Borg
3Aix Marseille Univ, Centre de Recherche en Cancérologie de Marseille (CRCM), Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’, Inserm, CNRS, Institut Paoli-Calmettes, Marseille (France)
7Institut Universitaire de France (IUF)
Sima Lev
2Weizmann Institute of Science, Department of Molecular Cell Biology, Rehovot (Israel)
Flavio Maina
1Aix Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille (France)
Posted August 10, 2020.
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
Fabienne Lamballe, Fahmida Ahmad, Yaron Vinik, Olivier Castellanet, Fabrice Daian, Anna-Katharina Müller, Ulrike A. Köhler, Anne-Laure Bailly, Emmanuelle Josselin, Rémy Castellano, Christelle Cayrou, Emmanuelle Charafe-Jauffret, Gordon B. Mills, Vincent Géli, Jean-Paul Borg, Sima Lev, Flavio Maina
bioRxiv 2020.06.22.164418; doi: https://doi.org/10.1101/2020.06.22.164418
Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
Fabienne Lamballe, Fahmida Ahmad, Yaron Vinik, Olivier Castellanet, Fabrice Daian, Anna-Katharina Müller, Ulrike A. Köhler, Anne-Laure Bailly, Emmanuelle Josselin, Rémy Castellano, Christelle Cayrou, Emmanuelle Charafe-Jauffret, Gordon B. Mills, Vincent Géli, Jean-Paul Borg, Sima Lev, Flavio Maina
bioRxiv 2020.06.22.164418; doi: https://doi.org/10.1101/2020.06.22.164418
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)